This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Sep 2026 quarter: revenue down 30% year-on-year, profit after tax up 13% to Rs 242 lakh
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 0.6 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone quarter ended 30 September 2026: revenue from operations fell 29.8% to Rs 11,761.19 lakh from Rs 16,764.30 lakh a year earlier; profit after tax rose 12.9% to Rs 242.01 lakh from Rs 214.42 lakh. The margin for operating earnings before interest, depreciation and tax widened to 3.3% from 0.5%. Standalone half-year: revenue Rs 13,170.25 lakh, loss after tax Rs 83.17 lakh, and operating cash outflow Rs 2,379.44 lakh.
Quarterly profit and margins improved, but falling revenue and negative operating cash flow may limit near-term share-price gains.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹117.6 Cr | ₹167.6 Cr | −29.8% |
| Operating profit | −₹2.16 Cr | −₹4.97 Cr | loss narrowed |
| Profit after tax | ₹2.42 Cr | ₹2.14 Cr | +12.9% |
| EBITDA margin | 3.3% | 0.6% | +2.7 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.